Yunfan Lin
Overview
Explore the profile of Yunfan Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Y, Lin P, Xu R, Chen X, Lu Y, Zheng J, et al.
Theranostics
. 2025 Mar;
15(7):3098-3121.
PMID: 40083941
Cancer immunotherapy leveraging nanovaccines represents a cutting-edge frontier in precision medicine, specifically designed to potentiate CD8 T cell-based immunotherapy. This review thoroughly delineates the evolving landscape of cancer nanovaccine development,...
2.
Chen X, Mai Z, Zheng Y, Lin P, Lu Y, Zheng J, et al.
Int J Biol Macromol
. 2025 Jan;
297:139895.
PMID: 39818393
R-loops, three-stranded nucleic acid structures composed of RNA-DNA hybrids, are increasingly recognized as central regulators of genomic stability and transcription. These structures play critical roles across various cellular processes, including...
3.
Cui L, Mai Z, Lu Y, Zheng J, Lin P, Chen X, et al.
Int Endod J
. 2025 Jan;
58(4):587-603.
PMID: 39815670
Aim: Effective control of mesenchymal stem cell (MSC) differentiation towards osteogenic lineages is fundamental for bone regeneration. This study elucidates the regulatory role of methyltransferase like 7A (METTL7A) in the...
4.
Lin P, Lin Y, Mai Z, Zheng Y, Zheng J, Zhou Z, et al.
Theranostics
. 2025 Jan;
15(1):300-323.
PMID: 39744228
T cell receptor-engineered T (TCR-T) cell therapies are at the forefront of cancer immunotherapy, offering a transformative approach that significantly enhances the ability of T cells to recognize and eliminate...
5.
Xu R, Lin P, Zheng J, Lin Y, Mai Z, Lu Y, et al.
Mater Today Bio
. 2025 Jan;
30:101386.
PMID: 39742149
Advancements in cancer therapy have increasingly focused on leveraging the synergistic effects of combining immunotherapy with other treatment modalities, facilitated by the use of innovative nanoplatforms. These strategies aim to...
6.
P-type accumulation mode organic electrochemical transistor biosensor for xanthine detection in fish
Lin Y, Kroon R, Zeglio E, Herland A
Biosens Bioelectron
. 2024 Nov;
269:116928.
PMID: 39549310
Food waste is a global challenge that needs to be mitigated in the development of more sustainable societies. From manufacturers to customers, food biosensors could effectively reduce the amount of...
7.
Zheng Y, Xu R, Chen X, Lu Y, Zheng J, Lin Y, et al.
Cell Death Dis
. 2024 Oct;
15(10):775.
PMID: 39461979
The tumor microenvironment (TME) orchestrates a complex interplay between tumor cells and immune cells, crucially modulating the immune response. This review delves into the pivotal role of metabolic reprogramming in...
8.
Zhou Z, Zheng J, Lu Y, Mai Z, Lin Y, Lin P, et al.
Exp Hematol Oncol
. 2024 Oct;
13(1):103.
PMID: 39438986
CD8 T cells are integral to the effective management of cancer and infectious diseases due to their cytotoxic functions. The efficacy of these cells is profoundly influenced by their metabolic...
9.
Zheng J, Shu D, Xu R, Zheng Y, Lin P, Lin Y, et al.
Curr Med Chem
. 2024 Oct;
PMID: 39411955
Aim: This study seeks to develop a prognostic risk signature for head and neck squamous cell carcinoma (HNSCC) based on cholesterol-related genes (CholRG), aiming to enhance prognostic accuracy in clinical...
10.
Lin Y, Lin P, Lu Y, Zheng J, Zheng Y, Huang X, et al.
Adv Sci (Weinh)
. 2024 Oct;
11(44):e2406318.
PMID: 39377984
RNA-modifying proteins, classified as "writers," "erasers," and "readers," dynamically modulate RNA by adding, removing, or interpreting chemical groups, thereby influencing RNA stability, functionality, and interactions. To date, over 170 distinct...